STEVEN KARO: Open Payments
NPI 1407854789 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,684 in 91 payments from 22 companies in 2025. Trend: 2023 $745 · 2024 $1,114 · 2025 $1,684
Food & beverage: $1,684
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $263 |
| Amgen Inc. | 15 | $204 |
| Esperion Therapeutics, Inc. | 9 | $170 |
| Novo Nordisk Inc | 8 | $148 |
| GlaxoSmithKline, LLC. | 12 | $135 |
| PFIZER INC. | 5 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $116 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| INTUITIVE SURGICAL, INC. | 1 | $85 |
| Astellas Pharma US Inc | 3 | $49 |
Products named: NEXLETOL, QULIPTA, NURTEC ODT, XIFAXAN, TRELEGY ELLIPTA, OTEZLA, GEMTESA, Da Vinci Surgical System.
Industry payments across FL — which companies pay providers there.
